JP2011074047A - Process of humus extract - Google Patents
Process of humus extract Download PDFInfo
- Publication number
- JP2011074047A JP2011074047A JP2009230184A JP2009230184A JP2011074047A JP 2011074047 A JP2011074047 A JP 2011074047A JP 2009230184 A JP2009230184 A JP 2009230184A JP 2009230184 A JP2009230184 A JP 2009230184A JP 2011074047 A JP2011074047 A JP 2011074047A
- Authority
- JP
- Japan
- Prior art keywords
- humus
- extract
- soil
- humus extract
- bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003864 humus Substances 0.000 title claims abstract description 119
- 239000000284 extract Substances 0.000 title claims abstract description 52
- 238000000034 method Methods 0.000 title abstract description 15
- 230000008569 process Effects 0.000 title abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000002689 soil Substances 0.000 claims abstract description 20
- 239000008262 pumice Substances 0.000 claims abstract description 9
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 7
- AWYFVXROQOFXKI-UHFFFAOYSA-J calcium magnesium tetraacetate hydrate Chemical compound O.C(C)(=O)[O-].[Ca+2].[Mg+2].C(C)(=O)[O-].C(C)(=O)[O-].C(C)(=O)[O-] AWYFVXROQOFXKI-UHFFFAOYSA-J 0.000 claims abstract description 5
- 238000004519 manufacturing process Methods 0.000 claims description 19
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 230000032683 aging Effects 0.000 claims description 8
- 231100000419 toxicity Toxicity 0.000 abstract description 6
- 230000001988 toxicity Effects 0.000 abstract description 6
- 230000008029 eradication Effects 0.000 abstract 1
- 230000003641 microbiacidal effect Effects 0.000 abstract 1
- 229940124561 microbicide Drugs 0.000 abstract 1
- 239000002855 microbicide agent Substances 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 description 25
- 241000894006 Bacteria Species 0.000 description 17
- 230000000844 anti-bacterial effect Effects 0.000 description 17
- 230000001954 sterilising effect Effects 0.000 description 17
- 239000000645 desinfectant Substances 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 238000000855 fermentation Methods 0.000 description 11
- 230000004151 fermentation Effects 0.000 description 11
- 239000000126 substance Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 241000700605 Viruses Species 0.000 description 7
- 244000052616 bacterial pathogen Species 0.000 description 7
- 230000009471 action Effects 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000010865 sewage Substances 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000003899 bactericide agent Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000012224 working solution Substances 0.000 description 3
- 229930192334 Auxin Natural products 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000002363 auxin Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 230000001877 deodorizing effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- 230000008635 plant growth Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000010802 sludge Substances 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- PUKLDDOGISCFCP-JSQCKWNTSA-N 21-Deoxycortisone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2=O PUKLDDOGISCFCP-JSQCKWNTSA-N 0.000 description 1
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- FCYKAQOGGFGCMD-UHFFFAOYSA-N Fulvic acid Natural products O1C2=CC(O)=C(O)C(C(O)=O)=C2C(=O)C2=C1CC(C)(O)OC2 FCYKAQOGGFGCMD-UHFFFAOYSA-N 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000276569 Oryzias latipes Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000002509 fulvic acid Substances 0.000 description 1
- 229940095100 fulvic acid Drugs 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 239000003617 indole-3-acetic acid Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 231100000017 mucous membrane irritation Toxicity 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000002688 soil aggregate Substances 0.000 description 1
- 239000003516 soil conditioner Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
本発明は、腐植抽出液の製造方法に関し、より詳細には、生長促進剤や殺菌剤としてより高い効果を示す腐植抽出液の製造方法に関する。 The present invention relates to a method for producing a humus extract, and more particularly, to a method for producing a humus extract exhibiting a higher effect as a growth promoter or fungicide.
腐植は、落葉樹の落ち葉と有機物・無機物がおよそ8千年間地中に埋蔵されて発酵と熟成を繰り返して生成された腐植土に含まれる物質である。腐植には、フミン酸、フルボ酸、ミネラル、アミノ酸、ビタミン、その他の有用菌等が含まれている。腐植は、以下示す多くの特徴を有する:
(1)pH緩衝作用が大きい、
(2)キレート反応をする、
(3)陽イオン交換容量が高い、
(4)土壌の団粒構造を形成する、
(5)生理活性機能がある、
(6)病原菌を抑制する、
(7)動植物の生育障害防止作用がある、
(8)脱臭作用がある、
(9)汚水の清浄作用がある、
(10)汚水処理工程で汚泥削減効果がある、
(11)抗酸化作用がある。
Humus is a substance contained in humus soil that has been produced by repeated fermentation and ripening of fallen leaves and organic and inorganic substances buried in the ground for approximately 8,000 years. Humus contains humic acid, fulvic acid, minerals, amino acids, vitamins, and other useful bacteria. Humus has many characteristics:
(1) pH buffering action is large,
(2) chelate reaction,
(3) High cation exchange capacity,
(4) forming a soil aggregate structure;
(5) has a physiologically active function,
(6) suppress pathogenic bacteria,
(7) It has the effect of preventing the growth of plants and animals.
(8) Deodorizing action
(9) There is a cleansing action of sewage,
(10) There is a sludge reduction effect in the sewage treatment process,
(11) Has an antioxidant effect.
腐植の使用目的に応じて、上記の少なくとも一種の特徴を最大限発揮できるように、腐植を様々な形態と組成物を応用する。例えば、汚水処理用に各種形状の腐植を含む汚水浄化促進剤、汚泥削減剤として腐植粉剤、脱臭用として腐植ペレット・腐植粉剤、土壌改良剤として腐植抽出液、病原菌、ウイルス抑制のために殺菌・殺ウイルス剤腐植抽出液、保湿、殺菌、整肌効果を有する化粧水として腐植抽出液等が挙げられる。 Depending on the intended use of the humus, various forms and compositions of the humus are applied so that at least one of the above characteristics can be exhibited to the maximum. For example, sewage purification accelerator containing various forms of humus for sewage treatment, humus powder as sludge reduction agent, humus pellet / humus powder as deodorizing agent, humus extract as soil conditioner, sterilization / control for pathogenic bacteria, virus As a lotion having a virucidal agent humus extract, moisturizing, sterilizing and skin conditioning effects, humus extract and the like can be mentioned.
腐植は、ペレット、粉末や抽出液の形態で使用することになるが、自然界で作られる腐植資源は有限であるため、腐植による効果を大きくして使用量を減らすといったできるだけ効率的な使用が望まれる。さらに、従来の分野に加えて、新しい分野や用途で社会に貢献できることも望まれる。 Humus is used in the form of pellets, powders and extracts. However, since humus resources produced in nature are limited, it is desirable to use them as efficiently as possible by increasing the effects of humus and reducing the amount used. It is. Furthermore, in addition to the conventional fields, it is also desired to contribute to society in new fields and applications.
病原菌、特に感染症病原菌やインフルエンザウイルスの抑制のために、減菌、消毒、洗浄が大切である。従来の減菌、消毒法には、物理的方法として過熱、ろ過、紫外線の方法があり、化学的方法としてグルタルアルデヒド、次亜塩素酸ナトリウム、エタノール、クロヘキシジン等の消毒薬がある。いずれの方法を採用するかによって、消毒効果が変わる。 Sterilization, disinfection, and cleaning are important to control pathogens, especially infectious diseases and influenza viruses. Conventional sterilization and disinfection methods include physical methods such as superheating, filtration, and ultraviolet rays, and chemical methods include disinfectants such as glutaraldehyde, sodium hypochlorite, ethanol, and chlorhexidine. The disinfection effect changes depending on which method is adopted.
上記方法によっては使用上の制限もある。例えば、煮沸、熱水等の物理的方法は、鋼製や磁製の小物や食器に適用できるが、生体や環境には使用できない。 Depending on the method, there is a limitation in use. For example, physical methods such as boiling and hot water can be applied to steel and magnetic accessories and tableware, but cannot be used for living bodies and the environment.
化学的消毒薬は、一般に、人体への毒性、皮膚への損傷、残留毒性が懸念される。例えば、グルタアルデヒドは、高水準の消毒効果を示すが、人体への毒性が強い。よく知られている次亜塩素酸ナトリウムやエタノールは、中水準の消毒効果を示すが、粘膜や損傷皮膚には使用できない。ほかに、化学的消毒薬は、金属腐蝕の問題も発生する。 Chemical disinfectants are generally concerned with toxicity to the human body, damage to the skin, and residual toxicity. For example, glutaraldehyde exhibits a high level of disinfection effect, but is highly toxic to the human body. Well-known sodium hypochlorite and ethanol show a moderate level of disinfection, but cannot be used on mucous membranes or damaged skin. In addition, chemical disinfectants also cause metal corrosion problems.
このように使用上の制約がある消毒薬と比べて人体への残留毒性がなく安全な消毒薬が求められている。その一策として、腐植抽出液を抗菌剤として使用する技術が、特許文献1〜4で提案されている。特に、特許文献2には、粗乾燥と精密乾燥とによる腐植土に水を加えて抽出を行ない、得られた抽出液を0.1〜0.3μmのフィルターを用いて濾過することにより得られた濾液からなる腐植土抽出物質含有水性液が記載されている。また、特許文献4には、腐植土を含水率50〜80%に保って明反応させることにより製造される腐植と、その腐植を水に抽出することにより製造される腐植抽出液が記載されている。
しかし、腐植抽出液を用いた従来の抗菌剤では、大腸菌、サルモネラ菌、黄色ブドウ球菌に対して、使用開始後2〜24時間経過時でも、生菌が検出され、抗菌性は満足される結果が得られていない。 However, with the conventional antibacterial agent using the humus extract, viable bacteria are detected against E. coli, Salmonella and Staphylococcus aureus even after 2 to 24 hours have elapsed from the start of use, and antibacterial properties are satisfied. Not obtained.
従来の腐植抽出液を殺菌剤として使用しても除菌率で必ずしも満足できない現状において、本発明の目的は、人体への毒性がなく、安全性に優れた殺菌剤として使用でき、そして高い除菌率が使用開始直後から安定して得られる殺菌剤の製造方法を提供することにある。 In the present situation where the sterilization rate is not always satisfactory even when the conventional humus extract is used as a bactericidal agent, the object of the present invention is that it is not toxic to the human body, can be used as a bactericidal agent with excellent safety, and has high sterilization efficiency. An object of the present invention is to provide a method for producing a bactericide that can be stably obtained immediately after the start of use.
本発明者が過去に提示した特許文献4に記載の製造方法により得られる腐植抽出液(以下、腐植抽出液Aという)に含まれている細菌を殺菌して、抗菌作用への影響を調べた。その結果を表1に示す。 Bacteria contained in the humus extract (hereinafter referred to as humus extract A) obtained by the production method described in Patent Document 4 presented by the present inventor was sterilized, and the effect on the antibacterial action was examined. . The results are shown in Table 1.
2)腐植抽出液の殺菌は、121℃、15分の熱殺菌とした。
2) Sterilization of the humus extract was performed at 121 ° C. for 15 minutes.
表1から、腐植抽出液Aに生存する細菌が抗菌作用に影響を及ぼしていることがわかる。その細菌はバチルス属細菌が主であることを他の実験で確認した。この細菌は腐植成分が多いところに特有の生存菌なので、腐植抽出液の抗菌作用は、細菌が主原因であるが細菌が生存する環境成分である腐植成分もまた原因のひとつであると考えられる。 From Table 1, it can be seen that the bacteria that survive in the humus extract A have an effect on the antibacterial action. It was confirmed by other experiments that the bacterium was mainly Bacillus. Since this bacterium is a viable bacteria peculiar to a lot of humus components, the antibacterial action of the humus extract is thought to be due to the humus component, which is an environmental component where bacteria are the main cause, but the bacteria survive. .
本発明者らの経験では、病原菌が増殖するところではフザリウム(グラム陰性菌)の占有率が高く、腐植成分が減少している。病原菌の発生がないところでは放線菌、バチルス属細菌等のグラム陽性菌が多くアミノ酸、有機酸、ビタミン、その他の生理活性物質が多く、腐植成分が増加している傾向がある。この傾向がすべて合致するものではないが、病原菌と腐植土との関係を示すものとして腐植成分が多いと病原菌を抑制している。 In the experience of the present inventors, the occupancy rate of fusarium (gram-negative bacteria) is high and the humic component is reduced where the pathogenic bacteria grow. In the absence of pathogenic bacteria, there are many Gram-positive bacteria such as actinomycetes and Bacillus bacteria, and there are many amino acids, organic acids, vitamins, and other physiologically active substances, and the humic component tends to increase. Although all of these tendencies do not match, if there are many humus components that indicate the relationship between pathogenic bacteria and humus soil, pathogens are suppressed.
一方、腐植成分が豊富な環境下に存在するバチルス属細菌により病原菌を抑制することも判った。この条件に合うように発酵と熟成に工夫を重ねて、腐植抽出液の抗菌性の改善を試みた。その結果、以下の発明によれば、上記課題を解決できることが判明した。すなわち、本発明は、以下の工程:(1)腐植土を含水率50〜80%に保って明反応させ、(2)得られる腐植を、水および酢酸マグネシウムカルシウム水和物と混合し、発酵および熟成させることからなる、腐植抽出液の製造方法を提供する。 On the other hand, it was also found that pathogenic bacteria are suppressed by Bacillus bacteria present in an environment rich in humic components. We tried to improve the antibacterial properties of the humus extract by repeating the fermentation and aging to meet these conditions. As a result, it has been found that the following problems can be solved according to the following invention. That is, the present invention comprises the following steps: (1) light reaction with humus soil kept at a moisture content of 50 to 80%, (2) the obtained humus is mixed with water and magnesium calcium acetate hydrate, and fermented And a method for producing a humus extract comprising aging.
本明細書で、明反応とは、掘削した腐植土を太陽光のもとで乾燥させずに含水率を50〜80%に保って発酵と熟成させることをいう。なお、土中での腐植の反応を暗反応という。 In the present specification, the light reaction means that the excavated humus soil is not dried under sunlight and the moisture content is maintained at 50 to 80% and fermented and matured. The reaction of humus in the soil is called dark reaction.
工程(2)で、前記腐植に、さらにスキムミルクを混合することが好ましい。 In step (2), it is preferable that skim milk is further mixed with the humus.
工程(2)で、前記腐植に、さらに軽石を混合することが好ましい。 In the step (2), it is preferable to further mix pumice with the humus.
本発明では、腐植土を明反応させて得られる腐植土に、特定の添加物を加えて発酵および熟成させることにより、従来よりもさらに抗菌性の高い腐植抽出液を製造することができた。 In the present invention, a humus extract having a higher antibacterial property than before can be produced by adding specific additives to humus obtained by light reaction of humus and fermenting and aging.
従来は消毒剤の噴霧法は消毒薬を人体が吸い込む等の理由であまり使用されなくなっていた。しかし、本発明の製造方法により得られる腐植抽出液を消毒剤として噴霧法で使用すると、人体への毒性はなく、空間の殺菌を簡単に行なうことができる。 Conventionally, the disinfectant spraying method has not been used much because the human body inhales the disinfectant. However, when the humus extract obtained by the production method of the present invention is used as a disinfectant in the spray method, there is no toxicity to the human body, and the space can be easily sterilized.
本発明の腐植抽出液の製造方法は、以下の工程:
(1)腐植土を含水率50〜80%に保って明反応させ、
(2)得られる腐植に、水および酢酸マグネシウムカルシウム水和物を混合し、発酵および熟成させることからなる。その詳細を以下に説明する。
The method for producing a humus extract of the present invention includes the following steps:
(1) The humus soil is kept at a moisture content of 50 to 80% to cause a light reaction,
(2) The obtained humus is mixed with water and magnesium calcium acetate hydrate, fermented and matured. Details thereof will be described below.
工程(1)は、特許文献4(特開2006−273734)に記載の腐植の製造方法と同様であるので、特許文献4の内容を本明細書に参照のために編入する。以下に、工程(1)の概要を示す。 Since step (1) is the same as the method for producing humus described in Patent Document 4 (Japanese Patent Laid-Open No. 2006-273734), the contents of Patent Document 4 are incorporated herein by reference. Below, the outline | summary of a process (1) is shown.
工程(1)で用いる腐植土は、落葉樹の落ち葉、樹木などの有機物由来の分解・生合成物が、通常、例えば約8000年間以上の間、地下に埋蔵されて、腐植化されたものである。腐植土の年代は、例えば共存する花粉で年数測定すれば求まる。 The humus soil used in step (1) is a deciduous, fallen leaf, decomposed or biosynthetic material derived from organic matter such as trees that has been buried in the basement for, for example, about 8000 years or more. . The age of the humus can be obtained, for example, by measuring the years with coexisting pollen.
工程(1)では、掘削した腐植土に明反応を行なわせる。すなわち、太陽光の下、通常、1〜12ヶ月、好ましくは3〜12ヶ月、特に好ましくは、6〜12ヶ月放置する。 In step (1), a light reaction is performed on the excavated humus soil. That is, it is usually left under sunlight for 1 to 12 months, preferably 3 to 12 months, particularly preferably 6 to 12 months.
工程(1)で、地上の腐植土の含水率は、50〜80%であり、好ましくは50〜70%、さらに好ましくは50〜65%と、発酵に適した含水率を維持する必要がある。地下の腐植土の含水率は、好ましくは50〜80%を保つ。 In step (1), the moisture content of the humus soil on the ground is 50 to 80%, preferably 50 to 70%, more preferably 50 to 65%, and it is necessary to maintain a moisture content suitable for fermentation. . The moisture content of the underground humus is preferably maintained at 50-80%.
腐植土全体を均一に明反応させるために、時々、切り返しを行うことが好ましい。 In order to make the whole humus soil lightly react uniformly, it is sometimes preferable to cut back.
腐植土は、掘削時にpH=約7の中性であるが、地上での明反応を進めると、1ヶ月経過後にはpH=3程度になる。1年経過後しても、pHの大きな変化はなく、pH=2.6〜3.3になる。 The humus soil is neutral at a pH of about 7 when excavated, but when the light reaction on the ground is advanced, the pH becomes about 3 after one month. Even after one year, there is no significant change in pH, and the pH is 2.6 to 3.3.
工程(2)では、前記工程で得られた腐植から、腐植成分を水へ抽出する。工程(1)で用いる腐植土や工程(1)で得られる腐植は、植物の生長促進や生理活性機能の作用をもち、植物ホルモンとして知られているインドール酢酸(オーキシン)と似た作用を示す。腐植の化学構造は一定していないが、Schulten(1993年)らによる代表的な化学構造モデルを以下に示す。 In the step (2), humic components are extracted into water from the humus obtained in the step. The humus soil used in step (1) and the humus obtained in step (1) have the effects of promoting plant growth and bioactive functions, and are similar to indoleacetic acid (auxin) known as a plant hormone. . Although the chemical structure of humus is not constant, a typical chemical structure model by Schulten et al. (1993) is shown below.
この分子は高分子であるが、その構造式中に、下記構造式のオーキシンと類似の構造が含まれている。 Although this molecule is a polymer, its structural formula includes a structure similar to auxin of the following structural formula.
工程(1)で得られる腐植のオーキシン様効果を増幅させるために、酢酸を添加したいが、酢酸を腐植に直接添加したのでは酢酸が生物反応で分解される。本発明では、工程(2)で、水内に抽出される腐植成分に酢酸マグネシウムカルシウム水和物(以下、CMAという)とキレート反応させることで、酢酸の分解反応を阻止する。CMAの添加により、実施例に示すとおり、病原菌の殺菌作用が増幅する。また、生長促進、癒傷効果の促進にもなる。 In order to amplify the auxin-like effect of the humus obtained in step (1), it is desired to add acetic acid. However, if acetic acid is added directly to the humus, the acetic acid is decomposed by a biological reaction. In the present invention, in the step (2), the humic component extracted in water is chelated with magnesium calcium acetate hydrate (hereinafter referred to as CMA) to prevent the decomposition reaction of acetic acid. Addition of CMA amplifies the bactericidal action of pathogenic bacteria as shown in the Examples. It also promotes growth and promotes wound healing effects.
前記CMAの添加量は、腐植と水の合計に対して、通常、50〜1000ppmでよく、好ましくは100〜200ppmである。 The amount of CMA added is usually 50 to 1000 ppm, preferably 100 to 200 ppm, based on the total amount of humus and water.
工程(2)で、前記腐植に栄養源としてスキムミルクを添加することが好ましい。従来栄養源として知られるグルコースは雑菌が増殖するのに対して、スキンミルクは雑菌の増殖が少ない。しかも、スキンミルクは、腐植土に生存するバチルス層細菌を増殖する。スキムミルクは、バチルス属菌を増殖し、この細菌による抗菌作用を増幅する。スキムミルクは、特に制限されず、市販のものでよい。 In step (2), it is preferable to add skim milk as a nutrient source to the humus. Glucose grows conventionally in glucose, which is known as a nutrient source, whereas skin milk has little growth of bacteria. Moreover, skin milk grows Bacillus layer bacteria that survive in humus. Skimmed milk grows Bacillus and amplifies the antibacterial action of this bacterium. The skim milk is not particularly limited and may be commercially available.
前記スキムミルクの添加量は、腐植と水の合計に対して、通常、50〜200ppmでよく、好ましくは50〜100ppmである。 The amount of skim milk added is usually 50 to 200 ppm, preferably 50 to 100 ppm, based on the total amount of humus and water.
工程(2)で、微生物を円滑に増殖させるために、前記腐植に軽石を混合することが好ましい。特に、できるだけ多種類のミネラルを含む軽石が好ましい。軽石の代表的な成分を表2に示す。 In step (2), it is preferable to mix pumice with the humus in order to allow the microorganisms to grow smoothly. In particular, pumice containing as many kinds of minerals as possible is preferable. Table 2 shows typical components of pumice.
前記軽石の添加量は、腐植と水の合計に対して、通常、0.1〜1.0重量%でよく、好ましくは0.1〜0.2重量%である。 The addition amount of the pumice is usually 0.1 to 1.0% by weight, preferably 0.1 to 0.2% by weight, based on the total amount of humus and water.
工程(2)の発酵および熟成時には、上記成分のほかに、適宜、アミノ酸の一種であるシステインを例えば約100ppm添加混合してもよい。 At the time of fermentation and aging in step (2), in addition to the above components, for example, about 100 ppm of cysteine which is a kind of amino acid may be added and mixed.
工程(2)で、腐植の含水率は、通常、15〜50%でよく、好ましくは15〜40%、特に好ましくは20〜30%である。 In the step (2), the moisture content of the humus is usually 15 to 50%, preferably 15 to 40%, particularly preferably 20 to 30%.
工程(2)の発酵および熟成の温度は、室温でよい。また、発酵および熟成の期間は、通常、2〜12カ月間でよく、好ましくは3〜4カ月間である。 The fermentation and aging temperature in step (2) may be room temperature. The period of fermentation and aging is usually 2 to 12 months, preferably 3 to 4 months.
工程(2)の熟成および発酵の間に、前半の2〜4カ月間は、曝気と槽内攪拌を続け、そして、残る1〜2カ月間は静止沈降させることが好ましい。 During the ripening and fermentation in step (2), it is preferable to continue aeration and stirring in the tank for the first 2 to 4 months, and to perform static sedimentation for the remaining 1 to 2 months.
工程(2)の間に、腐植成分が水中に溶解・溶出すると共に、水中では発酵と生合成が進行し、アミノ酸、ビタミンなどの生理活性物質が増加する。とりわけ、抽出の初期に黄褐色を呈した混合液が、6ヶ月以上の経過でアルギニン、システイン、ヒスチジン、チロシン等に見られる赤色呈色を示すと共に、全アミノ酸が増加する。腐植と水とを混合した当初のpHは、3〜3.5であるが、6〜12ヶ月の発酵によって、pH=2〜3程度になる。 During the step (2), the humic component dissolves and elutes in water, and fermentation and biosynthesis proceed in water, increasing physiologically active substances such as amino acids and vitamins. In particular, a mixed solution that exhibits a yellowish brown color at the initial stage of extraction shows red coloration seen in arginine, cysteine, histidine, tyrosine, etc. after 6 months or more, and all amino acids increase. The initial pH of the mixture of humus and water is 3 to 3.5, but it becomes about pH = 2 to 3 by fermentation for 6 to 12 months.
工程(2)で得られた腐植の上澄液またはろ液を、腐植抽出液とする。ろ過には、ろ紙またはカセットフィルターを使用すればよい。 The humus supernatant or filtrate obtained in step (2) is used as the humus extract. For the filtration, a filter paper or a cassette filter may be used.
消毒薬の使用目的は、感染経路の遮断や病原体の排除である。感染を防ぐには、滅菌、消毒および/または洗浄が予防措置になる。消毒を効果的に行なうには、作用時間、作用濃度、作用温度が重要である。市場の化学的消毒薬は、消毒後、残留毒性を除去するために、洗浄をしなければならない。 The purpose of disinfectants is to block infection routes and eliminate pathogens. To prevent infection, sterilization, disinfection and / or cleaning are precautions. The action time, action concentration, and action temperature are important for effective disinfection. Commercial chemical disinfectants must be cleaned after disinfection to remove residual toxicity.
本発明の製造方法により得られる腐植抽出液は、マウスの急性経口毒性試験、マウスの皮膚刺激試験、眼粘膜刺激試験、ヒメダカ毒性試験等多くの安全試験で安全性を確認されている。この材料を消毒剤としてしようすると、残留毒性がないので洗浄する必要がない。従って、人体にも金属にも使用して洗浄の必要がないので、消毒剤が対象物に長時間付着していることになり、抗菌作用が大きくなる。さらに、抗酸化作用があるので、金属腐蝕が避けられる。 The humus extract obtained by the production method of the present invention has been confirmed to be safe in many safety tests such as an acute oral toxicity test in mice, a skin irritation test in mice, an ocular mucosal irritation test, and a medaka toxicity test. If this material is used as a disinfectant, there is no residual toxicity and no cleaning is required. Therefore, since it is not necessary to clean it by using it on the human body or metal, the disinfectant adheres to the object for a long time, and the antibacterial action increases. Furthermore, since it has an antioxidant action, metal corrosion is avoided.
本発明の製造方法により得られる腐植抽出液は、消毒剤として、器材や人体への噴霧、塗布、浸漬で殺菌、加湿器の水に添加して噴霧殺菌、空気循環器への取組み、空気殺菌、マスクに含浸殺菌化粧水への添加殺菌、浴槽への添加脱臭殺菌、リネン類への含浸殺菌等に使用できる。 The humus extract obtained by the production method of the present invention is sterilized by spraying, coating and dipping on equipment and the human body as a disinfectant, adding to the water of a humidifier, spray sterilization, working on an air circulator, air sterilization It can be used for addition sterilization to impregnated sterilization lotion on mask, addition deodorization sterilization to bathtub, impregnation and sterilization to linens.
本発明の製造方法により得られる腐植抽出液の使用濃度は、腐植抽出原液(上澄液やろ液)でもよく、さらに最高20倍に薄めても抗菌効果を発揮する。したがって、上記用途に応じて、腐植抽出原液の通常、1〜10倍希釈液、好ましくは5〜10倍希釈液を使用すればよい。 The use concentration of the humus extract obtained by the production method of the present invention may be a humus extract undiluted solution (supernatant solution or filtrate), and further exhibits antibacterial effects even when diluted up to 20 times. Therefore, according to the said use, what is necessary is just to use normally 1-10 times dilution liquid of a humus extraction undiluted solution, Preferably 5-10 times dilution liquid may be used.
以下に、実施例および比較例を示して、本発明をより詳細に説明する。ただし、本発明は以下の実施例に限定されない。
〔実施例1〕
(工程1)
エンザイム株式会社長崎工場敷地内で約8000年間地下に埋蔵されていた腐植土を掘削し、太陽光の下、常温で約12ヶ月間、明反応を行った。この明反応により、酵素および補酵素の含有量を高めた腐植の物性を表3に示す。
Hereinafter, the present invention will be described in more detail with reference to Examples and Comparative Examples. However, the present invention is not limited to the following examples.
[Example 1]
(Process 1)
The humus soil that had been buried underground for about 8,000 years at the site of Enzyme's Nagasaki Plant was excavated and light reaction was performed for about 12 months at room temperature under sunlight. Table 3 shows the physical properties of humus in which the content of enzymes and coenzymes was increased by this light reaction.
(工程2)
工程1で得られた腐植と水とを重量比30:70の割合で混合した(腐植の含水率は50%となる)。その混合物に栄養剤として市販のスキンミルク100ppm、生理活性化剤としてCMA100ppm、微生物増殖用支持体として軽石0.1重量%を添加して、常温で3〜12ヶ月間発酵を熟成した。熟成から2〜11ヶ月間は曝気と槽内攪拌を続け、そして残る1ヶ月間は静止沈降させた。上澄液をろ紙またはカセットフィルターでろ過して、腐植抽出液を得た。腐植抽出液の物性を表4に示す。
(Process 2)
The humus obtained in step 1 and water were mixed at a weight ratio of 30:70 (the moisture content of the humus was 50%). 100 ppm of commercially available skin milk as a nutrient, 100 ppm of CMA as a bioactive agent, and 0.1% by weight of pumice as a support for microbial growth were added to the mixture, and fermentation was matured at room temperature for 3 to 12 months. Aeration and stirring in the tank were continued for 2 to 11 months from aging, and static sedimentation was performed for the remaining 1 month. The supernatant was filtered through a filter paper or a cassette filter to obtain a humus extract. Table 4 shows the physical properties of the humus extract.
〔比較例1〕
比較(ポジティブコントロール)のために、エンザイム株式会社長崎工場敷地内で得た腐植土を用いて特開2006−273734に記載の製造方法に従って腐植抽出液を調製した。具体的には、実施例1の工程(2)において、スキンミルク、CMA、および軽石を混合しなかった以外は、実施例1と同様の手順で、腐植抽出液を調製した。この腐植抽出液の成分を表5に示す。表5の有機物、無機物ともに含有量は少量であるが、腐植抽出液は、腐植成分、ミネラル、微生物、酵素、補酵素が含まれた活性化された液といえる。
[Comparative Example 1]
For comparison (positive control), a humus extract was prepared according to the production method described in JP-A-2006-273734 using humus soil obtained in the site of Enzyme Nagasaki Factory. Specifically, a humus extract was prepared in the same procedure as in Example 1 except that skin milk, CMA, and pumice were not mixed in Step (2) of Example 1. The components of this humus extract are shown in Table 5. Although the contents of both organic and inorganic substances in Table 5 are small, the humus extract can be said to be an activated liquid containing humic components, minerals, microorganisms, enzymes, and coenzymes.
実施例1の腐植抽出液(表4)と、比較例1の腐植抽出液(表5)とでは、成分にほとんど差が出ない。しかし、実施例1では発酵途中で細菌叢に差が見られたことがら、以下の抗菌試験で、両者の抗菌作用に差が生ずるか否かを確かめた。 There is almost no difference in components between the humus extract of Example 1 (Table 4) and the humus extract of Comparative Example 1 (Table 5). However, in Example 1, since a difference was observed in the bacterial flora during the fermentation, it was confirmed in the following antibacterial test whether or not there was a difference in the antibacterial action of both.
(抗菌試験)
実施例1および比較例1の腐植抽出液に、大腸菌、緑膿菌、サルモネラ菌または黄色ブドウ球菌の菌液を接種後、25℃で保存し、60秒、6時間、および、24時間後、それぞれ、試験液中の生菌数を測定した。その結果を表6に示す。また、比較(ネガティブコントロール)として、試験液を精製水に変えた試験を追加した。
(Antimicrobial test)
After inoculating Escherichia coli, Pseudomonas aeruginosa, Salmonella or Staphylococcus aureus into the humus extract of Example 1 and Comparative Example 1, it was stored at 25 ° C., and after 60 seconds, 6 hours, and 24 hours, respectively. The number of viable bacteria in the test solution was measured. The results are shown in Table 6. As a comparison (negative control), a test in which the test solution was changed to purified water was added.
2)開始時:菌液接種直後の対照の生菌数を測定し、開始時とした。
表6から、実施例1および比較例1のいずれも高い抗菌作用を示すことがわかる。実施例1の腐植抽出液は、比較例1の腐植抽出液と比べて大腸菌の除菌率でほぼ同じ数値を示しているが、他の菌の除菌率では高い数値を示した。 From Table 6, it can be seen that both Example 1 and Comparative Example 1 exhibit high antibacterial activity. The humus extract of Example 1 showed almost the same numerical value in terms of the sterilization rate of Escherichia coli as compared with the humus extract of Comparative Example 1, but showed a high value in the sterilization rate of other bacteria.
(ウイルス不活性化試験)
この試験に先立ち予備試験を行ない、ウイルス感染価の測定法について検討した。実施例1の腐植抽出液の原液では十分な不活性化が予測できたので、注射用水を用いて腐植抽出液の5倍液を調製して、本試験を行なうことにした。さらに、細胞維持培地で作用液を100倍に希釈して感染価を測定した。また、比較(ネガティブコントロール)として、試験液を精製水に変えた試験を追加した。
(Virus inactivation test)
Prior to this test, a preliminary test was conducted to examine a method for measuring the viral infectivity titer. Since sufficient inactivation could be predicted with the stock solution of the humus extract of Example 1, it was decided to carry out this test by preparing a 5-fold solution of the humus extract using water for injection. Furthermore, the infectivity titer was measured by diluting the working fluid 100 times with a cell maintenance medium. As a comparison (negative control), a test in which the test solution was changed to purified water was added.
実施例1の腐植抽出液の5倍希釈液にインフルエンザウイルスのウイルス浮遊液((財)日本食品分析センターより入手)を混合し、作用液とした。室温で作用させ、60秒、6時間、および24時間後、それぞれ、作用液のウイルス感染価を測定した。測定結果を表7に示す。 A virus suspension of influenza virus (obtained from Japan Food Analysis Center) was mixed with a 5-fold diluted solution of the humus extract of Example 1 to obtain a working solution. The solution was allowed to act at room temperature, and after 60 seconds, 6 hours, and 24 hours, the virus infectivity of the working solution was measured. Table 7 shows the measurement results.
<2.5:検出せず
logTCID50 :作用液1mlあたりのTCID50の対数値
1)開始時:作用開始直後の対照のTCID50を測定し、開始時とした。
2)精製水:ネガティブコントロール
2) Purified water: negative control
表7では、実施例1の腐植抽出液の5倍希釈液において、A型インフルエンザウイルスの感染価除去率が60秒後で99.9%、6時間後で99.999%以上となり、高率でウイルスを不活性化した。 In Table 7, in the 5-fold dilution of the humus extract of Example 1, the infectivity removal rate of influenza A virus was 99.9% after 60 seconds and 99.999% or more after 6 hours, with a high rate Inactivated the virus.
上記したように、実施例1の腐植抽出液と比較例1の腐植抽出液との差は微小に見えるもの、実施例1の腐植抽出液の抗菌性は、比較例1の腐植抽出液よりも優れ、さらにウイルス不活化試験で極めて良好なウイルス不活化作用を示す。感染症の病原体対策は滅菌(百万分の1まで除菌)と消毒で感染を遮断しなければならないことから、本発明の製造方法により、腐植抽出液の抗菌性をさらに高めたことは大きな収穫といえる。表6および7の良好な抗菌作用を得るために解釈しようとした課題の製造方法は、仮説から実用に移して成功した新しい発明といえる。 As described above, the difference between the humus extract of Example 1 and the humus extract of Comparative Example 1 appears to be minute, and the antibacterial property of the humus extract of Example 1 is higher than that of the humus extract of Comparative Example 1. Excellent, and also exhibits a very good virus inactivation action in virus inactivation tests. Since the pathogen countermeasures for infectious diseases must be blocked by sterilization (sterilization to 1 / 1,000,000) and disinfection, the production method of the present invention has greatly improved the antibacterial properties of the humus extract. It's a harvest. The manufacturing method of the problem which it tried to interpret in order to obtain the favorable antibacterial action of Table 6 and 7 can be said to be a new invention succeeded from a hypothesis to practical use.
Claims (3)
(1)腐植土を含水率50〜80%に保って明反応させ、
(2)得られる腐植を、水および酢酸マグネシウムカルシウム水和物と混合し、発酵および熟成させる
ことからなる、腐植抽出液の製造方法。 The following steps:
(1) The humus soil is kept at a moisture content of 50 to 80% to cause a light reaction,
(2) A method for producing a humus extract comprising mixing the obtained humus with water and magnesium calcium acetate hydrate, fermenting and aging.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009230184A JP5314555B2 (en) | 2009-10-02 | 2009-10-02 | Method for producing humus extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009230184A JP5314555B2 (en) | 2009-10-02 | 2009-10-02 | Method for producing humus extract |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011074047A true JP2011074047A (en) | 2011-04-14 |
JP5314555B2 JP5314555B2 (en) | 2013-10-16 |
Family
ID=44018404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009230184A Active JP5314555B2 (en) | 2009-10-02 | 2009-10-02 | Method for producing humus extract |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5314555B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013043988A (en) * | 2011-08-26 | 2013-03-04 | Toshi Kakugyo Kk | Urinary calculus removing agent |
WO2013065439A1 (en) * | 2011-11-01 | 2013-05-10 | 味の素株式会社 | Plant virus infection inhibitor and plant virus infection inhibition method using same |
JP2020048468A (en) * | 2018-09-26 | 2020-04-02 | エンザイム株式会社 | Cultivation method of aquatic animal |
WO2024080322A1 (en) * | 2022-10-13 | 2024-04-18 | 日本製紙株式会社 | Anti-white spot syndrome virus agent |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56167610A (en) * | 1980-05-28 | 1981-12-23 | Yoshihiko Takeshita | Germicide comprising extracted solution of humic acid |
JPS61112022A (en) * | 1984-05-07 | 1986-05-30 | Mamoru Uchimizu | Antibacterial preparation utilizing humus-forming reaction |
JPH02292385A (en) * | 1989-03-06 | 1990-12-03 | Chevron Res Co | Deicer composition containing magnesium-calcium acetate and chelating agent |
JPH1059861A (en) * | 1996-08-15 | 1998-03-03 | Keinzu Corp:Kk | Germicide |
JP2000136140A (en) * | 1998-10-29 | 2000-05-16 | Ra Purata Koeki Kk | Aqueous solution containing substance extracted from humic soil |
JP2006273734A (en) * | 2005-03-29 | 2006-10-12 | Enzyme Kk | Humus, humus extract solution, moisturizing liquid, their manufacturing method and use |
JP2008007451A (en) * | 2006-06-28 | 2008-01-17 | Ray & Company Inc | Sterilizer |
-
2009
- 2009-10-02 JP JP2009230184A patent/JP5314555B2/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56167610A (en) * | 1980-05-28 | 1981-12-23 | Yoshihiko Takeshita | Germicide comprising extracted solution of humic acid |
JPS61112022A (en) * | 1984-05-07 | 1986-05-30 | Mamoru Uchimizu | Antibacterial preparation utilizing humus-forming reaction |
JPH02292385A (en) * | 1989-03-06 | 1990-12-03 | Chevron Res Co | Deicer composition containing magnesium-calcium acetate and chelating agent |
JPH1059861A (en) * | 1996-08-15 | 1998-03-03 | Keinzu Corp:Kk | Germicide |
JP2000136140A (en) * | 1998-10-29 | 2000-05-16 | Ra Purata Koeki Kk | Aqueous solution containing substance extracted from humic soil |
JP2006273734A (en) * | 2005-03-29 | 2006-10-12 | Enzyme Kk | Humus, humus extract solution, moisturizing liquid, their manufacturing method and use |
JP2008007451A (en) * | 2006-06-28 | 2008-01-17 | Ray & Company Inc | Sterilizer |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013043988A (en) * | 2011-08-26 | 2013-03-04 | Toshi Kakugyo Kk | Urinary calculus removing agent |
WO2013065439A1 (en) * | 2011-11-01 | 2013-05-10 | 味の素株式会社 | Plant virus infection inhibitor and plant virus infection inhibition method using same |
US10617122B2 (en) | 2011-11-01 | 2020-04-14 | Ajinomoto Co., Inc. | Plant virus infection inhibitor and a method for inhibiting plant virus infection using the same |
JP2020048468A (en) * | 2018-09-26 | 2020-04-02 | エンザイム株式会社 | Cultivation method of aquatic animal |
JP7169502B2 (en) | 2018-09-26 | 2022-11-11 | エンザイム株式会社 | aquaculture method of aquatic animals |
WO2024080322A1 (en) * | 2022-10-13 | 2024-04-18 | 日本製紙株式会社 | Anti-white spot syndrome virus agent |
Also Published As
Publication number | Publication date |
---|---|
JP5314555B2 (en) | 2013-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109316536A (en) | A kind of skin mucosa disinfecting agent and preparation method thereof | |
JP3507347B2 (en) | Aqueous liquid containing humus extract material | |
KR20160079473A (en) | Preparation method of cleaning or disinfecting composition having antiviral activity by containing green tea extract as active component | |
KR20090129849A (en) | Deodorant composition and manufacturing method thereof | |
JP5281808B2 (en) | Food sterilization method using a food-use alcohol sanitizer that imparts antibacterial persistence and antiviral properties | |
JP5314555B2 (en) | Method for producing humus extract | |
CN101590287B (en) | Wound filling | |
US20060075922A1 (en) | Controlled-acidity composition | |
JP2008007451A (en) | Sterilizer | |
CN106309412A (en) | Compound ethanol disinfectant | |
KR100669204B1 (en) | Composition for deodorization and sterilization and its manufacturing process | |
CN114246185A (en) | Application of EDDHA (ethylene-vinyl acetate-docosahexaenoic acid) in preparation of medicine for resisting pathogenic bacteria of banana vascular wilt | |
JPS6391304A (en) | Liquid sterilizer | |
CN104430575B (en) | For the thimerosal and preparation method sterilized in ward | |
EP2181596B1 (en) | Method of inhibiting the growth of microorganism in aqueous systems using a composition comprising lysozyme | |
KR101732257B1 (en) | Eco-friendly oxygen radical composition for sterilization, disinfection and deodorization comprising extracts of thymus vulgaris l. | |
CA1039183A (en) | Oxydiacetaldehyde compositions and processes | |
EP1026144B1 (en) | Method of manufacturing an aromatic anti-bacterial agent containing hinokitiol | |
JPH08164192A (en) | Vegetative deodorant | |
WO2005075350A1 (en) | Hydrogen peroxide solution | |
CN111328811B (en) | Low-concentration alcohol sterilization disinfectant and application thereof | |
JP2007051111A (en) | Composition for disinfection and sterilization | |
JP6736342B2 (en) | Method for sterilizing grain seeds | |
CN111096340A (en) | Disinfectant concentrated solution for pet hospitals and preparation method thereof | |
CN110946995A (en) | Natural herbal deodorant and deinsectization disinfectant special for pets |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120529 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130314 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130321 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130514 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130604 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130611 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130702 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130705 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5314555 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |